Screening - METTLER TOLEDO

Screening

The initial process R&D phase of a drug candidate begins with screening. Screening can involve the investigation of solvent effects, reagent effects, etc. on a candidate’s activity level. The increased demand for more compounds released in a shorter period of time has resulted in a dramatic rise in the number of candidates that are screened per released drug. The level of screening candidates has now reached 10,000+ for every drug released to market.

Screening
Screening

Publications

Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they would on a newer browser version. If you would like to take full advantage of the site, please update your web browser to help improve your experience while browsing www.mt.com.